Cancer-Related Cognitive Impairments (CRCIs) in Non-Central Nervous System Adult Patients: Outcome Measures and Methodology of Assessment: A Literature Review
Background: Cancer-related cognitive impairment (CRCI) represents one of the most common and debilitating effects in patients surviving after cancer treatments. Neurocognitive deficits are important causes of disability and burden in cancer survivors. The true magnitude of CRCI is difficult to defin...
Saved in:
| Main Authors: | Andrea Pace, Antonio Tanzilli, Enrico Marchioni, Alessia Pellerino, Antonino Carmelo Tralongo, Paola Bini, Paolo Tralongo, Stefano Francesco Cappa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/14/11/1119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurological mechanism of the dietary supplementations of lycopene on chemotherapy-induced cognitive dysfunction/chemobrain and hippocampal toxicity in the rat model
by: Sunday Aderemi Adelakun, et al.
Published: (2025-12-01) -
Comparative Neurotoxic Effects of Doxorubicin and Sunitinib: An In Vitro Study on Human Dopaminergic Neuronal Cells
by: Maria Barbosa-Azevedo, et al.
Published: (2025-05-01) -
Chemotherapy and cognitive function: comprehensive review on methotrexate‐induced chemobrain
by: Nadine C. Sabry, et al.
Published: (2023-12-01) -
Dynamin-1 is a potential mediator in cancer-related cognitive impairment
by: Ding Quan Ng, et al.
Published: (2025-01-01) -
Doxorubicin causes cognitive impairment and alters gut microbiota in both male and female juvenile rats
by: Chadni Patel, et al.
Published: (2025-07-01)